Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-25-002077
Filing Date
2025-05-15
Accepted
2025-05-15 10:48:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 12315
  Complete submission text file 0001172661-25-002077.txt   13999
Mailing Address 650 SOUTH EXETER STREET SUITE 1070 BALTIMORE MD 21202
Business Address 650 SOUTH EXETER STREET SUITE 1070 BALTIMORE MD 21202 4102200129
Rock Springs Capital Management LP (Filed by) CIK: 0001595725 (see all company filings)

EIN.: 800944416 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Subject) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92962 | Film No.: 25949910
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)